Back to dashboard
All PlansAdministrativeMedium impact

[Ohio] Lenalidomide is now available with end‑to‑end REMS support

Anthem BCBS·OH · Oncology, Hematology·Provider Bulletin
Effective date
Not stated
We identified it
May 3, 2026
Days to comply
—

Summary

Lenalidomide, a cancer medication, is now available with comprehensive Risk Evaluation and Mitigation Strategy (REMS) support through Anthem Ohio. This change provides end-to-end support for prescribing and dispensing this controlled medication, potentially streamlining the authorization and dispensing process for oncology patients.

Action Required

Action needed
Immediately: Oncology billing team should contact Anthem Ohio to understand the new REMS support process for lenalidomide prescriptions. Update workflow procedures to incorporate the new end-to-end support system. Coordinate with providers to ensure they are aware of the enhanced REMS support when prescribing lenalidomide.

Related policy hubs